Understanding a bleeding disorder in newborns caused by maternal antibodies
Official title: The Immunobiology of Fetal/Neonatal Alloimmune Thrombocytopenia
Funded at Versiti Wisconsin, INC. · NIH-10934143 · Data updated 2026-11-12
This study is looking into Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT), a condition where a mother's antibodies can harm her baby's platelets, which might cause serious bleeding; researchers are using animal models to learn more about how these antibodies work so they can find better ways to diagnose and treat babies who are affected.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $618,750 |
| NIH project number | 1P01HL167668-01A1 |
| Project ID | NIH-10934143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include newborns diagnosed with FNAIT, particularly those with severe cases that may lead to major organ bleeds.
✕Less likely to help
Patients who are not newborns or those who do not have FNAIT or related bleeding disorders may not benefit from this research.
What this research studies
This research investigates Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT), a condition where maternal antibodies attack the platelets of a fetus or newborn, potentially leading to severe bleeding complications. The study aims to explore the mechanisms behind this disorder using a preclinical animal model to better understand how specific maternal antibodies affect platelet function and contribute to the severity of the condition. By identifying the characteristics of these antibodies, researchers hope to improve diagnosis and treatment options for affected infants.
Why it matters
Potential benefit: If successful, this research could lead to better management and treatment strategies for newborns suffering from FNAIT, reducing the risk of severe bleeding and associated complications.
How similar studies have gone: Previous research has shown promising results in understanding similar alloimmune conditions, suggesting that this approach may yield valuable insights into FNAIT.
Where this research is happening
-
Versiti Wisconsin, INC.
Milwaukee, United States Active
Researchers
- Principal investigator: Newman, Peter J — Versiti Wisconsin, INC.
- Study coordinator: Newman, Peter J
Related research
Other NIH-funded projects on the same topics.
-
New ideas to understand, diagnose, and treat heparin-induced thrombocytopenia
A Mayo Clinic led study will look at the different kinds of HIT antibodies to improve diagnosis and treatment for people with HIT.
-
Second-generation BLVRB inhibitors to help chemotherapy patients with low platelets
A new drug candidate is being developed to raise platelet counts in patients whose cancer treatment lowers them, reducing bleeding risk.
-
Immunobiology of vaccine-related clotting after adenovirus vaccines
This research asks how antibodies linked to a rare vaccine-related clotting condition (VITT) interact with specific blood proteins to cause clots after certain COVID-19 vaccines.
-
Understanding and diagnosing Heparin-Induced Thrombocytopenia (HIT)
A project to understand the immune factors behind HIT and develop faster, more accurate tests to help people who need heparin therapy.
-
Fetal and neonatal platelet allergy: understanding why some babies bleed
A study to understand why maternal antibodies cause serious bleeding in babies with FNAIT, using an animal model and human-relevant clues to improve future care for affected families.
-
Molecular mechanisms behind immune-related low platelets and clots in transfusion medicine
This grant supports a team of researchers to understand how immune factors cause low platelets and abnormal clots, with a focus on transfusion medicine and pediatric to adult patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.